tm logo
REZYLNEC
Live/Pending
PUBLICATION/ISSUE REVIEW COMPLETE

on 28 Nov 2024

Last Applicant/ Owned by

Serial Number

79398410 filed on 06th May 2024

Registration Number

N/A

Correspondent Address

Kathryn M. Eyster

Kathryn M. Eyster Tepper & Eyster, PLLC

Raleigh, NC 27609

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

REZYLNEC

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, centra Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79398410

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
30th Nov 2024REFUSAL PROCESSED BY IB
25th Nov 2024APPROVED FOR PUB - PRINCIPAL REGISTER
22nd Nov 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
22nd Nov 2024TEAS/EMAIL CORRESPONDENCE ENTERED
22nd Nov 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
12th Nov 2024REFUSAL PROCESSED BY MPU
12th Nov 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06th Nov 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05th Nov 2024NON-FINAL ACTION WRITTEN
28th Oct 2024ASSIGNED TO EXAMINER